Human papillomavirus vaccine CRADA
Executive Summary
National Cancer Institute announces in the April 7 Federal Register that it is seeking a pharmaceutical company to pursue development of a vaccine based on self-assembled human papillomavirus virion proteins to prevent infection of the human genital tract by human papillomaviruses.